Carr, Brian I; Akkiz, Hikmet; Üsküdar, Oguz et al. (2018) HCC with low- and normal-serum alpha-fetoprotein levels. Clin Pract (Lond) 15:453-464
|
Carr, Brian I; Akkiz, Hikmet; Guerra, Vito et al. (2018) C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors. Clin Pract (Lond) 15:625-634
|
Akkiz, Hikmet; Carr, Brian I; Yalç?n K, Kendal et al. (2018) Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients. Oncology 94:116-124
|
Akkiz, Hikmet; Carr, Brian I; Kuran, Sedef et al. (2018) Macroscopic Portal Vein Thrombosis in HCC Patients. Can J Gastroenterol Hepatol 2018:3120185
|
Carr, Brian I; Guerra, Vito; Giannini, Edoardo G et al. (2016) A Liver Index and its Relationship to Indices of HCC Aggressiveness. J Integr Oncol 5:
|
Pan?oška, Petr; Skála, Lubomír; Nešet?il, Jaroslav et al. (2015) Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis. Semin Oncol 42:339-46
|
D'Alessandro, Rosalba; Refolo, Maria Grazia; Lippolis, Catia et al. (2015) Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. Cancer Chemother Pharmacol 75:1237-1245
|
Carr, Brian I; Pancoska, Petr; Giannini, Edoardo G et al. (2014) Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters. Semin Oncol 41:406-414
|
D'Alessandro, Rosalba; Refolo, Maria G; Lippolis, Catia et al. (2014) Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. BMC Cancer 14:351
|
Carr, Brian I; Lin, Chih-Yun; Lu, Sheng-Nan (2014) Platelet-related phenotypic patterns in hepatocellular carcinoma patients. Semin Oncol 41:415-21
|
Showing the most recent 10 out of 55 publications